Rosuvastatin Treatment for Preventing Contrast-Induced Acute Kidney Injury After Cardiac Catheterization: A Meta-Analysis of Randomized Controlled Trials

We performed a meta-analysis of randomized controlled trials (RCTs) to evaluate the protective effects of rosuvastatin on contrast-induced acute kidney injury (CI-AKI) and major adverse cardiovascular events (MACEs) in patients undergoing cardiac catherization. PubMed, MEDLINE, Web of Science, EMBAS...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, You, Wu, Yan-xian, Hu, Yun-zhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554112/
https://www.ncbi.nlm.nih.gov/pubmed/26222855
http://dx.doi.org/10.1097/MD.0000000000001226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554112/
https://www.ncbi.nlm.nih.gov/pubmed/26222855
http://dx.doi.org/10.1097/MD.0000000000001226

Ejemplares similares